Lista de obras -

A Cost-Effectiveness Analysis of Nivolumab versus Docetaxel for Advanced Nonsquamous NSCLC Including PD-L1 Testing.

artículo científico publicado en 2016

A Vexing CA 125 Raise in a Patient with Pleural Effusion and Ovarian Cancer.

artículo científico publicado en 2017

A nurse is a nurse? A systematic review of the effectiveness of specialised nursing in breast cancer.

artículo científico publicado en 2006

A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.

artículo científico publicado en 2008

A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices.

artículo científico publicado en 1999

Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting

artículo científico publicado en 2011

Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII

artículo científico publicado en 2006

Adjuvant endocrine therapy for the very young patients.

artículo científico publicado en 2003

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10). ⬇️

artículo científico publicado en 2017

Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.

artículo científico publicado en 2007

Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences

artículo científico publicado en 2014

Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07).

artículo científico publicado en 2011

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). ⬇️

artículo científico publicado en 2015

Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial.

artículo científico publicado en 2004

Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

artículo científico publicado en 2017

Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases.

artículo científico publicado en 2019

Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.

artículo científico publicado en 2014

Chemotherapy--overview and future perspectives.

artículo científico publicado en 2006

Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early-onset fluoropyrimidine toxicity

artículo científico publicado en 2014

Combination chemotherapy with high-dose methotrexate and cytarabine with or without brain irradiation for primary central nervous system lymphomas.

artículo científico publicado en 2002

Complement activation and rituximab distribution in CNS NHL--letter

artículo científico publicado en 2015

Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference.

artículo científico publicado en 2007

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX.

artículo científico publicado en 2011

Dihydropyrimidinase and β-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity

scientific article published on 05 August 2015

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.

artículo científico publicado en 2016

Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK

scientific article published on 01 January 2006

Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.

artículo científico publicado en 2018

Endometrial cancer: a frequent orphan disease

article

Epidermal growth factor enhances cisplatin-induced apoptosis by a caspase 3 independent pathway.

artículo científico publicado en 2001

Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

artículo científico publicado en 2008

First international consensus guidelines for breast cancer in young women (BCY1).

artículo científico

Genomic aberrations and late recurrence in postmenopausal women with hormone receptor-positive early breast cancer: Results from the SOLE Trial

artículo científico publicado en 2020

High-dose chemotherapy for ovarian cancer: are we ready to go?

artículo científico publicado en 2001

Infiltrating lobular carcinoma of the breast: systemic treatment.

artículo científico publicado en 2008

Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial.

artículo científico publicado en 2002

MET Inhibition Results in DNA Breaks and Synergistically Sensitizes Tumor Cells to DNA-Damaging Agents Potentially by Breaching a Damage-Induced Checkpoint Arrest ⬇️

artículo científico publicado el 1 de octubre de 2010

Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research

artículo científico publicado en 2014

Male Breast Cancer: What is Different?

artículo científico publicado en 2016

Medical treatment of nasal squamous papilloma with imiquimod cream.

artículo científico publicado en 2003

Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.

artículo científico publicado en 2006

Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib Therapy.

artículo científico

Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases

artículo científico publicado en 2018

Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity.

artículo científico publicado en 2017

PRO_10 – A New Tissue-Based Prognostic Multigene Marker in Patients with Early Estrogen Receptor-Positive Breast Cancer

artículo científico publicado en 2011

Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.

artículo científico publicado en 2016

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

artículo científico publicado en 2011

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

artículo científico publicado en 2010

Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancer.

artículo científico publicado en 2004

Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer.

artículo científico publicado en 2008

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.

artículo científico publicado en 2007

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

artículo científico publicado en 2019

Rapid response to trastuzumab emtansine in a patient with HER2-driven lung cancer.

artículo científico publicado en 2015

Reply to 'Staging for distant metastases in operable breast cancer: a suggested expansion of the ESMO guideline recommendation for staging imaging of node-negative, hormonal receptor-negative disease' by U. Gueth et al.

artículo científico publicado en 2013

Response to Pembrolizumab in a Patient with Relapsing Thymoma

artículo científico publicado en 2016

Retinoid receptors in ovarian cancer: expression and prognosis.

artículo científico publicado en 2005

Routine adjuvant use of bisphosphonates in breast cancer arguments in favour and against.

artículo científico publicado en 2010

Special issues related to the adjuvant therapy in very young women.

artículo científico publicado en 2005

Spotlight on pomalidomide: could less be more?

artículo científico publicado en 2017

Successful AZD9291 Therapy Based on Circulating T790M.

artículo científico publicado en 2015

The Notch pathway in ovarian carcinomas and adenomas.

artículo científico publicado en 2005

The enigma of young age

artículo científico publicado en 2006

The impact of ABCC11 polymorphisms on the risk of early-onset fluoropyrimidine toxicity

artículo científico publicado en 2016

Trastuzumab treatment beyond progression in advanced breast cancer: patterns of care in six Swiss breast cancer centers

scientific article published on 28 October 2011

Treatment of premenopausal women with early breast cancer: old challenges and new opportunities.

artículo científico publicado en 2007

Lista de obras de

A Cost-Effectiveness Analysis of Nivolumab versus Docetaxel for Advanced Nonsquamous NSCLC Including PD-L1 Testing.

A Vexing CA 125 Raise in a Patient with Pleural Effusion and Ovarian Cancer.

A nurse is a nurse? A systematic review of the effectiveness of specialised nursing in breast cancer.

A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.

A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices.

Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting

Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII

Adjuvant endocrine therapy for the very young patients.

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10). ⬇️

Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group.

Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences

Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07).

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2). ⬇️

Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial.

Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases.

Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.

Chemotherapy--overview and future perspectives.

Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early-onset fluoropyrimidine toxicity

Combination chemotherapy with high-dose methotrexate and cytarabine with or without brain irradiation for primary central nervous system lymphomas.

Complement activation and rituximab distribution in CNS NHL--letter

Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference.

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX.

Dihydropyrimidinase and β-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity

Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99.

Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK

Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.

Endometrial cancer: a frequent orphan disease

Epidermal growth factor enhances cisplatin-induced apoptosis by a caspase 3 independent pathway.

Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

First international consensus guidelines for breast cancer in young women (BCY1).

Genomic aberrations and late recurrence in postmenopausal women with hormone receptor-positive early breast cancer: Results from the SOLE Trial

High-dose chemotherapy for ovarian cancer: are we ready to go?

Infiltrating lobular carcinoma of the breast: systemic treatment.

Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial.

MET Inhibition Results in DNA Breaks and Synergistically Sensitizes Tumor Cells to DNA-Damaging Agents Potentially by Breaching a Damage-Induced Checkpoint Arrest ⬇️

Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research

Male Breast Cancer: What is Different?

Medical treatment of nasal squamous papilloma with imiquimod cream.

Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.

Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib Therapy.

Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases

Novel Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related Toxicity.

PRO_10 – A New Tissue-Based Prognostic Multigene Marker in Patients with Early Estrogen Receptor-Positive Breast Cancer

Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Prognosis of dermal lymphatic invasion with or without clinical signs of inflammatory breast cancer.

Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer.

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

Rapid response to trastuzumab emtansine in a patient with HER2-driven lung cancer.

Reply to 'Staging for distant metastases in operable breast cancer: a suggested expansion of the ESMO guideline recommendation for staging imaging of node-negative, hormonal receptor-negative disease' by U. Gueth et al.

Response to Pembrolizumab in a Patient with Relapsing Thymoma

Retinoid receptors in ovarian cancer: expression and prognosis.

Routine adjuvant use of bisphosphonates in breast cancer arguments in favour and against.

Special issues related to the adjuvant therapy in very young women.

Spotlight on pomalidomide: could less be more?

Successful AZD9291 Therapy Based on Circulating T790M.

The Notch pathway in ovarian carcinomas and adenomas.

The enigma of young age

The impact of ABCC11 polymorphisms on the risk of early-onset fluoropyrimidine toxicity

Trastuzumab treatment beyond progression in advanced breast cancer: patterns of care in six Swiss breast cancer centers

Treatment of premenopausal women with early breast cancer: old challenges and new opportunities.